How many institutions held IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in Q2 2021?

110 institutional investors reported IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Q: What does CUSIP 45258J102 represent in this 13F holders report?

CUSIP 45258J102 is the security identifier for IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45258J102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 202,731,676
Total 13F shares: 38,555,821
Share change: -1,695,600
Total reported value: $407,535,405
Put/Call ratio: 25%
Price per share: $10.57
Number of holders: 110
Value change: -$67,673,203
Number of buys: 66
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 45258J102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	3.1%	6,356,743	$101,962,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	2%	3,996,720	$64,107,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	1.8%	3,685,016	$59,109,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1.8%	3,615,760	$57,997,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.2%	2,473,000	$39,667,000	—	31 Mar 2021	13F
BVF INC/IL	13F	Company	0.56%	1,144,016	$18,350,000	—	31 Mar 2021	13F
Alpine Global Management, LLC	13F	Company	0.54%	1,096,978	$17,596,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.52%	1,046,381	$16,784,000	—	31 Mar 2021	13F
Boxer Capital, LLC	13F	Company	0.49%	1,000,000	$16,040,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.44%	896,617	$14,382,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.42%	859,862	$13,792,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.39%	795,320	$12,756,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.38%	770,565	$12,360,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.37%	752,638	$12,072,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.29%	580,500	$9,311,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.28%	560,341	$8,988,000	—	31 Mar 2021	13F
One Fin Capital Management LP	13F	Company	0.27%	552,497	$8,862,000	—	31 Mar 2021	13F
Vivo Capital, LLC	13F	Company	0.26%	532,847	$8,547,000	—	31 Mar 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.25%	508,000	$8,148,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.09%	181,749	$8,064,000	—	31 Mar 2021	13F
MANGROVE PARTNERS IM, LLC	13F	Company	0.24%	485,368	$7,785,000	—	31 Mar 2021	13F
Opaleye Management Inc.	13F	Company	0.23%	467,000	$7,491,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.22%	449,651	$7,213,000	—	31 Mar 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.21%	430,015	$6,897,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.21%	429,962	$6,897,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.19%	377,309	$6,052,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	366,183	$5,874,000	—	31 Mar 2021	13F
Cormorant Asset Management, LP	13F	Company	0.17%	337,048	$5,406,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	331,487	$5,318,000	—	31 Mar 2021	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.15%	307,003	$4,924,000	—	31 Mar 2021	13F
Ally Bridge Group (NY) LLC	13F	Company	0.13%	260,000	$4,170,000	—	31 Mar 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.12%	250,000	$4,010,000	—	31 Mar 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.12%	249,311	$3,999,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.12%	242,621	$3,892,000	—	31 Mar 2021	13F
Eversept Partners, LP	13F	Company	0.11%	230,183	$3,692,135	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	0.11%	229,622	$3,683,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.1%	196,443	$3,151,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.1%	196,098	$3,145,000	—	31 Mar 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.09%	187,900	$3,014,000	—	31 Mar 2021	13F
ALPS ADVISORS INC	13F	Company	0.09%	177,246	$2,843,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	159,946	$2,566,000	—	31 Mar 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.08%	158,500	$2,542,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.07%	148,950	$2,389,000	—	31 Mar 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.07%	132,741	$2,129,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.06%	124,293	$1,993,000	—	31 Mar 2021	13F
BROOKFIELD Corp /ON/	13F	Company	0.05%	100,000	$1,604,000	—	31 Mar 2021	13F
SG Americas Securities, LLC	13F	Company	0.04%	90,479	$1,451,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.04%	83,130	$1,333,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.04%	77,500	$1,243,000	—	31 Mar 2021	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.04%	77,000	$1,235,000	—	31 Mar 2021	13F

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2021

As of 30 Jun 2021, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,555,821 shares. The largest 10 holders included STATE STREET CORP, VANGUARD GROUP INC, Woodline Partners LP, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., Alpine Global Management, LLC, MORGAN STANLEY, TWO SIGMA INVESTMENTS, LP, BVF INC/IL, and BOXER CAPITAL, LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

118

Q2 2021 holders

110

Holder diff

-8

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.